SAN DIEGO, Aug. 30, 2023 /PRNewswire/ — NuVasive, Inc. (NASDAQ: NUVA), the chief in spine know-how innovation, targeted on reworking spine surgical procedure with minimally disruptive, procedurally built-in options, right this moment introduced it’ll proceed its partnership with the Scoliosis Analysis Society (SRS) as a double diamond sponsor and can attend the 58th Annual Assembly held September 6-9, 2023, in Seattle.
“We accomplice with esteemed societies like SRS due to our shared dedication to medical analysis, training, and thought management round advancing affected person care, particularly within the difficult deformity section,” mentioned Chris Barry, chief govt officer at NuVasive. “SRS amplifies our potential to remodel complicated spine surgical procedure with extra clever and procedurally built-in deformity options.”
As a part of the SRS Annual Assembly, NuVasive will host a workshop on September 7, 2023, titled “Complicated Junctional Methods—The Good, The Unhealthy and The Ugly” introduced by school members Dr. Han Jo Kim, Dr. Tyler Koski, and Dr. Chris Shaffrey, and moderated by Dr. Rajiv Sethi. This case-based dialogue will cowl the panel’s experiences with their deformity sufferers and practices.
NuVasive has partnered with SRS, the premier worldwide society geared toward fostering optimum take care of all sufferers with spinal deformities, since 2007. The Firm’s ongoing double diamond sponsorship helps medical workshops, hands-on academic programs, fellowships, and grants for greater than 1,500 of the world’s main spine surgeons, researchers, doctor assistants, and orthotists concerned in researching and treating spinal deformities.
About NuVasive
NuVasive, Inc. (NASDAQ: NUVA) is the chief in spine know-how innovation, with a mission to remodel surgical procedure, advance care, and alter lives. The Firm’s less-invasive, procedurally built-in surgical options are designed to ship reproducible and clinically confirmed outcomes. The Firm’s complete procedural portfolio consists of surgical entry devices, spinal implants, fixation methods, biologics, software program for surgical planning, navigation and imaging options, magnetically adjustable implant methods for spine and orthopedics, and intraoperative neuromonitoring know-how and repair choices. With greater than $1 billion in web gross sales, NuVasive operates in additional than 50 international locations serving surgeons, hospitals, and sufferers. For extra data, please go to www.nuvasive.com.
Ahead-Wanting Statements
NuVasive cautions you that statements included on this information launch that aren’t an outline of historic details are forward-looking statements that contain dangers, uncertainties, assumptions and different components which, if they don’t materialize or show right, may trigger NuVasive’s outcomes to vary materially from historic outcomes or these expressed or implied by such forward-looking statements. The potential dangers and uncertainties which contribute to the unsure nature of those statements embrace, amongst others, dangers related to acceptance of the Firm’s surgical merchandise and procedures by spine surgeons and hospitals, improvement and acceptance of recent merchandise or product enhancements, medical and statistical verification of the advantages achieved by way of using NuVasive’s merchandise, the Firm’s capacity to adequately handle stock because it continues to launch new merchandise, its capacity to recruit and retain administration and key personnel, and the opposite dangers and uncertainties described in NuVasive’s information releases and periodic filings with the Securities and Change Fee. NuVasive’s public filings with the Securities and Change Fee can be found at www.sec.gov. NuVasive assumes no obligation to replace any forward-looking assertion to mirror occasions or circumstances arising after the date on which it was made.
SOURCE NuVasive, Inc.
Discussion about this post